Quidel to Acquire Ortho Clinical Diagnostics for ~$6.0B
Shots:
- Quidel to acquire Ortho Clinical Diagnostics for $24.68/share of common stock making a total equity value of $6.0B including $1.75B in cash & assume $2.0B in net debt representing a premium of 25% over Ortho’s closing price on Dec 22, 2021. The transaction is expected to close in H1’22
- The acquisition will boost Quidel’s global leadership in diagnostics by combining diagnostic portfolios with technologies & platforms that help to advance diagnostic solutions to improve patient outcomes & offers economic benefits to the healthcare system
- Ortho will receive $7.14 in cash & 0.1055 shares of common stock in the combined company for Ortho common share & is expected ~38% of a combined company
Ref: Quidel | Image: Ortho Clinical
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com